Drug class
Racetam nootropic; cognition-modulating pyrrolidone derivative
Mechanism of action
The precise mechanism is not fully established. Pramiracetam has been proposed to influence high-affinity choline uptake and cholinergic neurotransmission and to modulate learning- and memory-related neuronal signalling; it does not have a well-defined receptor agonist mechanism.
General use cases
- Used in some European countries for symptomatic treatment of concentration and memory disorders associated with degenerative or vascular brain pathology under national product authorisations. It is not approved for this use in all jurisdictions and clinical evidence remains limited.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
